DURVALUMAB PLUS TREMELIMUMAB FOR THE TREATMENT OF ADVANCED NEUROENDOCRINE NEOPLASMS OF GASTROENTEROPANCREATIC AND LUNG ORIGIN

Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin

Abstract Single immune checkpoint blockade in advanced neuroendocrine neoplasms (NENs) shows limited efficacy; dual checkpoint blockade may improve treatment activity.Dune (NCT03095274) is a non-randomized controlled multicohort phase II clinical trial evaluating durvalumab plus tremelimumab activity and safety in advanced NENs.This study included

read more

OPINION GIVING SERVICES AS A SOURCE OF CONSUMER INFORMATION

The goal of the article is to determine the place and role of opinion giving services in consumer behaviours.The discussion is conducted around the thesis saying that in the information society, opinion giving services THISILYN CLEANSE constitute an important source of information for consumers in the process of selecting and purchasing both produc

read more